Opportunity

DIBBS #SPE2DP-27-T-0282

DLA request for a package of premixed lidocaine and dextrose injection

Posted

November 12, 2026

Respond By

November 17, 2026

Identifier

SPE2DP-27-T-0282

NAICS

424210, 325412

DLA Troop Support is seeking one package of premixed lidocaine hydrochloride and dextrose injection for its Medical Supply Chain Pharmaceutical FSA. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact: Meghan Smink. - Product and quantity: 1 package of lidocaine hydrochloride and dextrose injection, 500 mL bags, 18 units per package (18 EA). - Identifiers: NSN 6505-01-194-7265; Baxter Healthcare Corp IV part number 2B0973P; NDC 00338-0409-03. - OEMs named: Baxter Healthcare Corp IV is the listed manufacturer. Hospira is also mentioned in connection with supply shortages. - Notable requirements: At least 16 months of the product's 18-month shelf life must remain when delivered. Delivery is required within 20 days after award. The notice describes limited supply availability and manufacturing delays affecting premixed lidocaine injections.

Description

LIDOCAINE HYDROCHLO (QTY: 1, NSN: 6505-01-194-7265, Purchase Request: 7013324492) Approved Sources: - CAGE: 04687, Part No: 2B0973P - CAGE: 04687, Part No: NDC00338-0409-03

View original listing